A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
Clinical trial NCT02748213 · COMPLETED
Trial details
- NCT number
- NCT02748213
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2006-03-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.